|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 122.08 CHF | +0.44% |
|
+3.48% | +11.39% |
| Jun. 12 | Analyst recommendations: Adobe, CME Group, Nvidia, Flutter… |  |
| Jun. 12 | Novartis' Rhapsido Meets Primary Endpoints in Chronic Inducible Urticaria Trial | MT |
| Market Cap | 281B 243B 223B 209B 392B 26,688B 398B 2,639B 1,029B 12,990B 1,054B 1,031B 44,979B | P/E Ratio 2026 * |
21.2x | P/E Ratio 2027 * | 18.2x |
|---|---|---|---|---|---|
| Enterprise Value | 313B 270B 249B 233B 437B 29,755B 444B 2,942B 1,147B 14,483B 1,175B 1,150B 50,146B | EV / Sales 2026 * |
5.49x | EV / Sales 2027 * | 5.12x |
| Free-Float |
91.66% | Yield 2026 * |
2.92% | Yield 2027 * | 3% |
Last Transcript: Novartis AG
| 1 day | +0.44% | ||
| 1 week | +3.48% | ||
| Current month | +3.62% | ||
| 1 month | +4.52% | ||
| 3 months | +0.59% | ||
| 6 months | +15.72% | ||
| Current year | +11.39% |
| 1 week | 116.42 |  | 122.9 |
| 1 month | 111.48 | | 122.9 |
| Current year | 107.68 | | 131 |
| 1 year | 91.2 | | 131 |
| 3 years | 81.1 | | 131 |
| 5 years | 72.84 | | 131 |
| 10 years | 65.09 | | 131 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 2018-01-31 | |
Mukul Mehta
DFI | Director of Finance/CFO | - | 2026-03-15 |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 64 | 2022-05-15 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 68 | 2014-12-31 |
| Director/Board Member | 69 | 2015-12-31 | |
Ton Büchner
BRD | Director/Board Member | 61 | 2015-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| May. 17 | Sell | -5,200 | 0.0003% | |||
| May. 03 | Sell | 6,800 | 0.0003% | |||
| Feb. 16 | Sell | 30,743 | 0.0015% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.44% | +3.48% | +25.65% | +35.66% | 281B | |
| -2.41% | +0.14% | +38.28% | +154.20% | 1,010B | |
| +1.07% | +3.48% | +53.32% | +49.85% | 580B | |
| +1.32% | +0.22% | +19.18% | +64.65% | 402B | |
| +0.77% | 0.00% | +21.28% | +16.70% | 330B | |
| -0.85% | -2.86% | +22.54% | +14.67% | 280B | |
| +1.66% | +1.20% | -44.35% | -47.35% | 197B | |
| +0.32% | +1.61% | +20.32% | +60.01% | 192B | |
| -0.22% | -2.76% | +14.19% | +60.09% | 156B | |
| +0.15% | +0.65% | +6.81% | -34.93% | 149B | |
| Average | +0.22% | +0.82% | +17.72% | +37.35% | 357.83B | |
| Weighted average by Cap. | -0.21% | +1.02% | +26.89% | +66.14% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 57.02B 49.25B 45.38B 42.48B 79.61B 5,420B 80.84B 536B 209B 2,638B 214B 209B 9,134B | 60.42B 52.19B 48.09B 45.02B 84.36B 5,743B 85.67B 568B 221B 2,796B 227B 222B 9,680B |
| Net income | 14.15B 12.22B 11.26B 10.54B 19.75B 1,345B 20.06B 133B 51.84B 655B 53.1B 51.97B 2,266B | 15.67B 13.54B 12.47B 11.68B 21.88B 1,490B 22.22B 147B 57.43B 725B 58.82B 57.57B 2,511B |
| Net Debt | 32.26B 27.86B 25.68B 24.03B 45.04B 3,066B 45.74B 303B 118B 1,493B 121B 118B 5,168B | 28.3B 24.44B 22.52B 21.08B 39.51B 2,690B 40.12B 266B 104B 1,309B 106B 104B 4,533B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-12 | 122.08 CHF | +0.44% | 2,443,439 |
| 26-06-11 | 121.54 CHF | +2.10% | 2,280,337 |
| 26-06-10 | 119.04 CHF | +0.56% | 2,499,056 |
| 26-06-09 | 118.38 CHF | +0.89% | 2,475,984 |
| 26-06-08 | 117.34 CHF | -0.54% | 2,182,444 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NOVN Stock
Select your edition
All financial news and data tailored to specific country editions
